Compare ACHV & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACHV | BHK |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.5M | 593.7M |
| IPO Year | 2018 | N/A |
| Metric | ACHV | BHK |
|---|---|---|
| Price | $6.80 | $8.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $14.15 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 427.9K |
| Earning Date | 11-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $8.03 |
| 52 Week High | $8.64 | $9.80 |
| Indicator | ACHV | BHK |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 57.13 |
| Support Level | $5.96 | N/A |
| Resistance Level | $7.30 | $9.16 |
| Average True Range (ATR) | 0.38 | 0.11 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 43.93 | 74.53 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.